Viewing nowCombinationSevisartan Tablets 5/20 Milligrams
Olmesartan Medoxomil 20mg · Amlodipine Orotate 6.91mg
Tablet · Prescription medication · Combination
Dong-A ST Co., Ltd.

MFDS item code 201405044 · Approved 2014.10.30 · Insurance code 642507120
Treatment of essential hypertension not controlled with monotherapy
This medication is used to effectively lower blood pressure in patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy with amlodipine or olmesartan medoxomil. It helps reduce the risk of complications due to hypertension and improve cardiovascular health.
Take 1 tablet once daily with water, regardless of meals. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or olmesartan medoxomil). However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to this medicine may be considered. The maximum dose of this medicine is 10/40 mg. The maximum blood pressure-lowering effect occurs within 2 weeks after administration; therefore, adjust the dose at intervals of 2 weeks or more, taking the patient's blood pressure response into account. The recommended doses are as follows: - 5/20 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or olmesartan medoxomil 20 mg as monotherapy. - 5/40 mg: For patients whose blood pressure is not adequately controlled with 5/20 mg. - 10/40 mg: For patients whose blood pressure is not adequately controlled with 5/40 mg. ∘Patients with renal impairment: This medicine has not been studied in patients with renal impairment. However, in patients with mild to moderate renal impairment (creatine clearance 20-60mL/min), the maximum dose of olmesartan medoxomil is 20 mg once daily. Use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. Monitoring of potassium and creatinine levels is recommended in patients with moderate renal impairment. ∘Patients with reduced effective intravascular volume: In patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended to start treatment at a low dose while carefully monitoring their condition. ∘Patients with hepatic impairment: Use with caution in patients with mild or moderate hepatic impairment. The recommended initial dose of olmesartan medoxomil in patients with moderate hepatic impairment is 10 mg once daily, and the maximum dose is 20 mg once daily. In patients with hepatic impairment who are already receiving other antihypertensive medicines and/or diuretics, blood pressure and renal function should be closely monitored. This medicine should not be administered to patients with severe hepatic impairment. (See section 2. Patients who should not take this medicine under Precautions for Use.) ∘Older adults: In general, start treatment at a low dose. When adjusting the dose, consider the patient's renal or cardiac function and comorbid conditions. In older adults, blood pressure should be monitored closely and more frequently.
Pediatric patients under 18 years of age: Safety and efficacy have not been established.
This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. It should not be administered to patients allergic to any of its components, those who are pregnant or breastfeeding, patients with severe liver disease or certain cardiovascular and renal conditions, and certain genetically predisposed lactose-intolerant patients. Patients with fluid or salt depletion should be closely monitored during the initial doses, as blood pressure may drop too low. Care should also be taken when using this medication in patients who may experience rapid vascular dilation leading to hypotension. Particular care should be taken in patients with heart disease or renal function issues, and those with impaired liver function when taking this medication. While taking this medication, side effects such as dizziness, headache, blood pressure drop, indigestion, and skin rash may occur, so patients should consult healthcare professionals if symptoms are severe or persistent. This medication may interact with other drugs, so patients should inform their doctors or pharmacists of any other medications they are currently taking. It is generally advised not to use this medication during pregnancy. If planning to get pregnant or if pregnant, patients should consult their doctor to find safe alternative treatments. Breastfeeding women should also be aware that this medication can be transmitted through breast milk and may affect the infant, so it is recommended to either stop breastfeeding or discontinue this medication. Safety and efficacy have not been established for use in children under the age of 18. In elderly patients, drug responses may vary due to decreased physical function, so it is preferable to start with a low dose and administer it carefully. In the case of overdose, hypotension and decreased cardiac function may occur, requiring immediate medical attention. This medication should be stored in a tightly sealed container to prevent exposure to sunlight, moisture, and heat, and kept out of reach of children; transferring it to another container may compromise its quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air and moisture exposure, and it is important to store it at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the efficacy of the medication and ensure its safe use.
White round film-coated tablets
30 tablets/PTP
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationOlmesartan Medoxomil 20mg · Amlodipine Orotate 6.91mg
Tablet · Prescription medication · Combination
Dong-A ST Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Orotate 13.82mg
Tablet · Prescription medication · Combination
Dong-A ST Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Orotate 6.91mg
Tablet · Prescription medication · Combination
Dong-A ST Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.